Medical Care
Global Humanized Monoclonal Antibody Market Research Report 2025
- Jan 17, 26
- ID: 676925
- Pages: 83
- Figures: 85
- Views: 14
This report aims to provide a comprehensive presentation of the global market for Humanized Monoclonal Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Humanized Monoclonal Antibody.
The Humanized Monoclonal Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Humanized Monoclonal Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Humanized Monoclonal Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Absolute Antibody
Amgen
Biotem
Creative Biolabs
Genentech
GenScript ProBio
Huston BioConsulting LLC
ImmunoGen
MorphoSys
MRC Laboratory of Molecular Biology
ProMab Biotechnologies
ProteoGenix
Sandoz International
Seattle Genetics
Zyngenia
Segment by Type
Fully Humanized Antibody
Humanized Antibody
Chimeric Antibody
Segment by Application
Laboratory Research
Clinical Drugs
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Humanized Monoclonal Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Humanized Monoclonal Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Humanized Monoclonal Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Humanized Monoclonal Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Absolute Antibody
Amgen
Biotem
Creative Biolabs
Genentech
GenScript ProBio
Huston BioConsulting LLC
ImmunoGen
MorphoSys
MRC Laboratory of Molecular Biology
ProMab Biotechnologies
ProteoGenix
Sandoz International
Seattle Genetics
Zyngenia
Segment by Type
Fully Humanized Antibody
Humanized Antibody
Chimeric Antibody
Segment by Application
Laboratory Research
Clinical Drugs
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Humanized Monoclonal Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Humanized Monoclonal Antibody Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Fully Humanized Antibody
1.2.3 Humanized Antibody
1.2.4 Chimeric Antibody
1.3 Market by Application
1.3.1 Global Humanized Monoclonal Antibody Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Laboratory Research
1.3.3 Clinical Drugs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Humanized Monoclonal Antibody Market Perspective (2020-2031)
2.2 Global Humanized Monoclonal Antibody Growth Trends by Region
2.2.1 Global Humanized Monoclonal Antibody Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Humanized Monoclonal Antibody Historic Market Size by Region (2020-2025)
2.2.3 Humanized Monoclonal Antibody Forecasted Market Size by Region (2026-2031)
2.3 Humanized Monoclonal Antibody Market Dynamics
2.3.1 Humanized Monoclonal Antibody Industry Trends
2.3.2 Humanized Monoclonal Antibody Market Drivers
2.3.3 Humanized Monoclonal Antibody Market Challenges
2.3.4 Humanized Monoclonal Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Humanized Monoclonal Antibody Players by Revenue
3.1.1 Global Top Humanized Monoclonal Antibody Players by Revenue (2020-2025)
3.1.2 Global Humanized Monoclonal Antibody Revenue Market Share by Players (2020-2025)
3.2 Global Humanized Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Humanized Monoclonal Antibody Revenue
3.4 Global Humanized Monoclonal Antibody Market Concentration Ratio
3.4.1 Global Humanized Monoclonal Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Humanized Monoclonal Antibody Revenue in 2024
3.5 Global Key Players of Humanized Monoclonal Antibody Head office and Area Served
3.6 Global Key Players of Humanized Monoclonal Antibody, Product and Application
3.7 Global Key Players of Humanized Monoclonal Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Humanized Monoclonal Antibody Breakdown Data by Type
4.1 Global Humanized Monoclonal Antibody Historic Market Size by Type (2020-2025)
4.2 Global Humanized Monoclonal Antibody Forecasted Market Size by Type (2026-2031)
5 Humanized Monoclonal Antibody Breakdown Data by Application
5.1 Global Humanized Monoclonal Antibody Historic Market Size by Application (2020-2025)
5.2 Global Humanized Monoclonal Antibody Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Humanized Monoclonal Antibody Market Size (2020-2031)
6.2 North America Humanized Monoclonal Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Humanized Monoclonal Antibody Market Size by Country (2020-2025)
6.4 North America Humanized Monoclonal Antibody Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Humanized Monoclonal Antibody Market Size (2020-2031)
7.2 Europe Humanized Monoclonal Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Humanized Monoclonal Antibody Market Size by Country (2020-2025)
7.4 Europe Humanized Monoclonal Antibody Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Humanized Monoclonal Antibody Market Size (2020-2031)
8.2 Asia-Pacific Humanized Monoclonal Antibody Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Humanized Monoclonal Antibody Market Size by Region (2020-2025)
8.4 Asia-Pacific Humanized Monoclonal Antibody Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Humanized Monoclonal Antibody Market Size (2020-2031)
9.2 Latin America Humanized Monoclonal Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Humanized Monoclonal Antibody Market Size by Country (2020-2025)
9.4 Latin America Humanized Monoclonal Antibody Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Humanized Monoclonal Antibody Market Size (2020-2031)
10.2 Middle East & Africa Humanized Monoclonal Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Humanized Monoclonal Antibody Market Size by Country (2020-2025)
10.4 Middle East & Africa Humanized Monoclonal Antibody Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Absolute Antibody
11.1.1 Absolute Antibody Company Details
11.1.2 Absolute Antibody Business Overview
11.1.3 Absolute Antibody Humanized Monoclonal Antibody Introduction
11.1.4 Absolute Antibody Revenue in Humanized Monoclonal Antibody Business (2020-2025)
11.1.5 Absolute Antibody Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Humanized Monoclonal Antibody Introduction
11.2.4 Amgen Revenue in Humanized Monoclonal Antibody Business (2020-2025)
11.2.5 Amgen Recent Development
11.3 Biotem
11.3.1 Biotem Company Details
11.3.2 Biotem Business Overview
11.3.3 Biotem Humanized Monoclonal Antibody Introduction
11.3.4 Biotem Revenue in Humanized Monoclonal Antibody Business (2020-2025)
11.3.5 Biotem Recent Development
11.4 Creative Biolabs
11.4.1 Creative Biolabs Company Details
11.4.2 Creative Biolabs Business Overview
11.4.3 Creative Biolabs Humanized Monoclonal Antibody Introduction
11.4.4 Creative Biolabs Revenue in Humanized Monoclonal Antibody Business (2020-2025)
11.4.5 Creative Biolabs Recent Development
11.5 Genentech
11.5.1 Genentech Company Details
11.5.2 Genentech Business Overview
11.5.3 Genentech Humanized Monoclonal Antibody Introduction
11.5.4 Genentech Revenue in Humanized Monoclonal Antibody Business (2020-2025)
11.5.5 Genentech Recent Development
11.6 GenScript ProBio
11.6.1 GenScript ProBio Company Details
11.6.2 GenScript ProBio Business Overview
11.6.3 GenScript ProBio Humanized Monoclonal Antibody Introduction
11.6.4 GenScript ProBio Revenue in Humanized Monoclonal Antibody Business (2020-2025)
11.6.5 GenScript ProBio Recent Development
11.7 Huston BioConsulting LLC
11.7.1 Huston BioConsulting LLC Company Details
11.7.2 Huston BioConsulting LLC Business Overview
11.7.3 Huston BioConsulting LLC Humanized Monoclonal Antibody Introduction
11.7.4 Huston BioConsulting LLC Revenue in Humanized Monoclonal Antibody Business (2020-2025)
11.7.5 Huston BioConsulting LLC Recent Development
11.8 ImmunoGen
11.8.1 ImmunoGen Company Details
11.8.2 ImmunoGen Business Overview
11.8.3 ImmunoGen Humanized Monoclonal Antibody Introduction
11.8.4 ImmunoGen Revenue in Humanized Monoclonal Antibody Business (2020-2025)
11.8.5 ImmunoGen Recent Development
11.9 MorphoSys
11.9.1 MorphoSys Company Details
11.9.2 MorphoSys Business Overview
11.9.3 MorphoSys Humanized Monoclonal Antibody Introduction
11.9.4 MorphoSys Revenue in Humanized Monoclonal Antibody Business (2020-2025)
11.9.5 MorphoSys Recent Development
11.10 MRC Laboratory of Molecular Biology
11.10.1 MRC Laboratory of Molecular Biology Company Details
11.10.2 MRC Laboratory of Molecular Biology Business Overview
11.10.3 MRC Laboratory of Molecular Biology Humanized Monoclonal Antibody Introduction
11.10.4 MRC Laboratory of Molecular Biology Revenue in Humanized Monoclonal Antibody Business (2020-2025)
11.10.5 MRC Laboratory of Molecular Biology Recent Development
11.11 ProMab Biotechnologies
11.11.1 ProMab Biotechnologies Company Details
11.11.2 ProMab Biotechnologies Business Overview
11.11.3 ProMab Biotechnologies Humanized Monoclonal Antibody Introduction
11.11.4 ProMab Biotechnologies Revenue in Humanized Monoclonal Antibody Business (2020-2025)
11.11.5 ProMab Biotechnologies Recent Development
11.12 ProteoGenix
11.12.1 ProteoGenix Company Details
11.12.2 ProteoGenix Business Overview
11.12.3 ProteoGenix Humanized Monoclonal Antibody Introduction
11.12.4 ProteoGenix Revenue in Humanized Monoclonal Antibody Business (2020-2025)
11.12.5 ProteoGenix Recent Development
11.13 Sandoz International
11.13.1 Sandoz International Company Details
11.13.2 Sandoz International Business Overview
11.13.3 Sandoz International Humanized Monoclonal Antibody Introduction
11.13.4 Sandoz International Revenue in Humanized Monoclonal Antibody Business (2020-2025)
11.13.5 Sandoz International Recent Development
11.14 Seattle Genetics
11.14.1 Seattle Genetics Company Details
11.14.2 Seattle Genetics Business Overview
11.14.3 Seattle Genetics Humanized Monoclonal Antibody Introduction
11.14.4 Seattle Genetics Revenue in Humanized Monoclonal Antibody Business (2020-2025)
11.14.5 Seattle Genetics Recent Development
11.15 Zyngenia
11.15.1 Zyngenia Company Details
11.15.2 Zyngenia Business Overview
11.15.3 Zyngenia Humanized Monoclonal Antibody Introduction
11.15.4 Zyngenia Revenue in Humanized Monoclonal Antibody Business (2020-2025)
11.15.5 Zyngenia Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Humanized Monoclonal Antibody Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Fully Humanized Antibody
1.2.3 Humanized Antibody
1.2.4 Chimeric Antibody
1.3 Market by Application
1.3.1 Global Humanized Monoclonal Antibody Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Laboratory Research
1.3.3 Clinical Drugs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Humanized Monoclonal Antibody Market Perspective (2020-2031)
2.2 Global Humanized Monoclonal Antibody Growth Trends by Region
2.2.1 Global Humanized Monoclonal Antibody Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Humanized Monoclonal Antibody Historic Market Size by Region (2020-2025)
2.2.3 Humanized Monoclonal Antibody Forecasted Market Size by Region (2026-2031)
2.3 Humanized Monoclonal Antibody Market Dynamics
2.3.1 Humanized Monoclonal Antibody Industry Trends
2.3.2 Humanized Monoclonal Antibody Market Drivers
2.3.3 Humanized Monoclonal Antibody Market Challenges
2.3.4 Humanized Monoclonal Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Humanized Monoclonal Antibody Players by Revenue
3.1.1 Global Top Humanized Monoclonal Antibody Players by Revenue (2020-2025)
3.1.2 Global Humanized Monoclonal Antibody Revenue Market Share by Players (2020-2025)
3.2 Global Humanized Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Humanized Monoclonal Antibody Revenue
3.4 Global Humanized Monoclonal Antibody Market Concentration Ratio
3.4.1 Global Humanized Monoclonal Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Humanized Monoclonal Antibody Revenue in 2024
3.5 Global Key Players of Humanized Monoclonal Antibody Head office and Area Served
3.6 Global Key Players of Humanized Monoclonal Antibody, Product and Application
3.7 Global Key Players of Humanized Monoclonal Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Humanized Monoclonal Antibody Breakdown Data by Type
4.1 Global Humanized Monoclonal Antibody Historic Market Size by Type (2020-2025)
4.2 Global Humanized Monoclonal Antibody Forecasted Market Size by Type (2026-2031)
5 Humanized Monoclonal Antibody Breakdown Data by Application
5.1 Global Humanized Monoclonal Antibody Historic Market Size by Application (2020-2025)
5.2 Global Humanized Monoclonal Antibody Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Humanized Monoclonal Antibody Market Size (2020-2031)
6.2 North America Humanized Monoclonal Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Humanized Monoclonal Antibody Market Size by Country (2020-2025)
6.4 North America Humanized Monoclonal Antibody Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Humanized Monoclonal Antibody Market Size (2020-2031)
7.2 Europe Humanized Monoclonal Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Humanized Monoclonal Antibody Market Size by Country (2020-2025)
7.4 Europe Humanized Monoclonal Antibody Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Humanized Monoclonal Antibody Market Size (2020-2031)
8.2 Asia-Pacific Humanized Monoclonal Antibody Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Humanized Monoclonal Antibody Market Size by Region (2020-2025)
8.4 Asia-Pacific Humanized Monoclonal Antibody Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Humanized Monoclonal Antibody Market Size (2020-2031)
9.2 Latin America Humanized Monoclonal Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Humanized Monoclonal Antibody Market Size by Country (2020-2025)
9.4 Latin America Humanized Monoclonal Antibody Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Humanized Monoclonal Antibody Market Size (2020-2031)
10.2 Middle East & Africa Humanized Monoclonal Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Humanized Monoclonal Antibody Market Size by Country (2020-2025)
10.4 Middle East & Africa Humanized Monoclonal Antibody Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Absolute Antibody
11.1.1 Absolute Antibody Company Details
11.1.2 Absolute Antibody Business Overview
11.1.3 Absolute Antibody Humanized Monoclonal Antibody Introduction
11.1.4 Absolute Antibody Revenue in Humanized Monoclonal Antibody Business (2020-2025)
11.1.5 Absolute Antibody Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Humanized Monoclonal Antibody Introduction
11.2.4 Amgen Revenue in Humanized Monoclonal Antibody Business (2020-2025)
11.2.5 Amgen Recent Development
11.3 Biotem
11.3.1 Biotem Company Details
11.3.2 Biotem Business Overview
11.3.3 Biotem Humanized Monoclonal Antibody Introduction
11.3.4 Biotem Revenue in Humanized Monoclonal Antibody Business (2020-2025)
11.3.5 Biotem Recent Development
11.4 Creative Biolabs
11.4.1 Creative Biolabs Company Details
11.4.2 Creative Biolabs Business Overview
11.4.3 Creative Biolabs Humanized Monoclonal Antibody Introduction
11.4.4 Creative Biolabs Revenue in Humanized Monoclonal Antibody Business (2020-2025)
11.4.5 Creative Biolabs Recent Development
11.5 Genentech
11.5.1 Genentech Company Details
11.5.2 Genentech Business Overview
11.5.3 Genentech Humanized Monoclonal Antibody Introduction
11.5.4 Genentech Revenue in Humanized Monoclonal Antibody Business (2020-2025)
11.5.5 Genentech Recent Development
11.6 GenScript ProBio
11.6.1 GenScript ProBio Company Details
11.6.2 GenScript ProBio Business Overview
11.6.3 GenScript ProBio Humanized Monoclonal Antibody Introduction
11.6.4 GenScript ProBio Revenue in Humanized Monoclonal Antibody Business (2020-2025)
11.6.5 GenScript ProBio Recent Development
11.7 Huston BioConsulting LLC
11.7.1 Huston BioConsulting LLC Company Details
11.7.2 Huston BioConsulting LLC Business Overview
11.7.3 Huston BioConsulting LLC Humanized Monoclonal Antibody Introduction
11.7.4 Huston BioConsulting LLC Revenue in Humanized Monoclonal Antibody Business (2020-2025)
11.7.5 Huston BioConsulting LLC Recent Development
11.8 ImmunoGen
11.8.1 ImmunoGen Company Details
11.8.2 ImmunoGen Business Overview
11.8.3 ImmunoGen Humanized Monoclonal Antibody Introduction
11.8.4 ImmunoGen Revenue in Humanized Monoclonal Antibody Business (2020-2025)
11.8.5 ImmunoGen Recent Development
11.9 MorphoSys
11.9.1 MorphoSys Company Details
11.9.2 MorphoSys Business Overview
11.9.3 MorphoSys Humanized Monoclonal Antibody Introduction
11.9.4 MorphoSys Revenue in Humanized Monoclonal Antibody Business (2020-2025)
11.9.5 MorphoSys Recent Development
11.10 MRC Laboratory of Molecular Biology
11.10.1 MRC Laboratory of Molecular Biology Company Details
11.10.2 MRC Laboratory of Molecular Biology Business Overview
11.10.3 MRC Laboratory of Molecular Biology Humanized Monoclonal Antibody Introduction
11.10.4 MRC Laboratory of Molecular Biology Revenue in Humanized Monoclonal Antibody Business (2020-2025)
11.10.5 MRC Laboratory of Molecular Biology Recent Development
11.11 ProMab Biotechnologies
11.11.1 ProMab Biotechnologies Company Details
11.11.2 ProMab Biotechnologies Business Overview
11.11.3 ProMab Biotechnologies Humanized Monoclonal Antibody Introduction
11.11.4 ProMab Biotechnologies Revenue in Humanized Monoclonal Antibody Business (2020-2025)
11.11.5 ProMab Biotechnologies Recent Development
11.12 ProteoGenix
11.12.1 ProteoGenix Company Details
11.12.2 ProteoGenix Business Overview
11.12.3 ProteoGenix Humanized Monoclonal Antibody Introduction
11.12.4 ProteoGenix Revenue in Humanized Monoclonal Antibody Business (2020-2025)
11.12.5 ProteoGenix Recent Development
11.13 Sandoz International
11.13.1 Sandoz International Company Details
11.13.2 Sandoz International Business Overview
11.13.3 Sandoz International Humanized Monoclonal Antibody Introduction
11.13.4 Sandoz International Revenue in Humanized Monoclonal Antibody Business (2020-2025)
11.13.5 Sandoz International Recent Development
11.14 Seattle Genetics
11.14.1 Seattle Genetics Company Details
11.14.2 Seattle Genetics Business Overview
11.14.3 Seattle Genetics Humanized Monoclonal Antibody Introduction
11.14.4 Seattle Genetics Revenue in Humanized Monoclonal Antibody Business (2020-2025)
11.14.5 Seattle Genetics Recent Development
11.15 Zyngenia
11.15.1 Zyngenia Company Details
11.15.2 Zyngenia Business Overview
11.15.3 Zyngenia Humanized Monoclonal Antibody Introduction
11.15.4 Zyngenia Revenue in Humanized Monoclonal Antibody Business (2020-2025)
11.15.5 Zyngenia Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Humanized Monoclonal Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Fully Humanized Antibody
Table 3. Key Players of Humanized Antibody
Table 4. Key Players of Chimeric Antibody
Table 5. Global Humanized Monoclonal Antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Humanized Monoclonal Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Humanized Monoclonal Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Humanized Monoclonal Antibody Market Share by Region (2020-2025)
Table 9. Global Humanized Monoclonal Antibody Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Humanized Monoclonal Antibody Market Share by Region (2026-2031)
Table 11. Humanized Monoclonal Antibody Market Trends
Table 12. Humanized Monoclonal Antibody Market Drivers
Table 13. Humanized Monoclonal Antibody Market Challenges
Table 14. Humanized Monoclonal Antibody Market Restraints
Table 15. Global Humanized Monoclonal Antibody Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Humanized Monoclonal Antibody Market Share by Players (2020-2025)
Table 17. Global Top Humanized Monoclonal Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Humanized Monoclonal Antibody as of 2024)
Table 18. Ranking of Global Top Humanized Monoclonal Antibody Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Humanized Monoclonal Antibody Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Humanized Monoclonal Antibody, Headquarters and Area Served
Table 21. Global Key Players of Humanized Monoclonal Antibody, Product and Application
Table 22. Global Key Players of Humanized Monoclonal Antibody, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Humanized Monoclonal Antibody Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Humanized Monoclonal Antibody Revenue Market Share by Type (2020-2025)
Table 26. Global Humanized Monoclonal Antibody Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Humanized Monoclonal Antibody Revenue Market Share by Type (2026-2031)
Table 28. Global Humanized Monoclonal Antibody Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Humanized Monoclonal Antibody Revenue Market Share by Application (2020-2025)
Table 30. Global Humanized Monoclonal Antibody Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Humanized Monoclonal Antibody Revenue Market Share by Application (2026-2031)
Table 32. North America Humanized Monoclonal Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Humanized Monoclonal Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Humanized Monoclonal Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Humanized Monoclonal Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Humanized Monoclonal Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Humanized Monoclonal Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Humanized Monoclonal Antibody Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Humanized Monoclonal Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Humanized Monoclonal Antibody Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Humanized Monoclonal Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Humanized Monoclonal Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Humanized Monoclonal Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Humanized Monoclonal Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Humanized Monoclonal Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Humanized Monoclonal Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 47. Absolute Antibody Company Details
Table 48. Absolute Antibody Business Overview
Table 49. Absolute Antibody Humanized Monoclonal Antibody Product
Table 50. Absolute Antibody Revenue in Humanized Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 51. Absolute Antibody Recent Development
Table 52. Amgen Company Details
Table 53. Amgen Business Overview
Table 54. Amgen Humanized Monoclonal Antibody Product
Table 55. Amgen Revenue in Humanized Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 56. Amgen Recent Development
Table 57. Biotem Company Details
Table 58. Biotem Business Overview
Table 59. Biotem Humanized Monoclonal Antibody Product
Table 60. Biotem Revenue in Humanized Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 61. Biotem Recent Development
Table 62. Creative Biolabs Company Details
Table 63. Creative Biolabs Business Overview
Table 64. Creative Biolabs Humanized Monoclonal Antibody Product
Table 65. Creative Biolabs Revenue in Humanized Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 66. Creative Biolabs Recent Development
Table 67. Genentech Company Details
Table 68. Genentech Business Overview
Table 69. Genentech Humanized Monoclonal Antibody Product
Table 70. Genentech Revenue in Humanized Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 71. Genentech Recent Development
Table 72. GenScript ProBio Company Details
Table 73. GenScript ProBio Business Overview
Table 74. GenScript ProBio Humanized Monoclonal Antibody Product
Table 75. GenScript ProBio Revenue in Humanized Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 76. GenScript ProBio Recent Development
Table 77. Huston BioConsulting LLC Company Details
Table 78. Huston BioConsulting LLC Business Overview
Table 79. Huston BioConsulting LLC Humanized Monoclonal Antibody Product
Table 80. Huston BioConsulting LLC Revenue in Humanized Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 81. Huston BioConsulting LLC Recent Development
Table 82. ImmunoGen Company Details
Table 83. ImmunoGen Business Overview
Table 84. ImmunoGen Humanized Monoclonal Antibody Product
Table 85. ImmunoGen Revenue in Humanized Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 86. ImmunoGen Recent Development
Table 87. MorphoSys Company Details
Table 88. MorphoSys Business Overview
Table 89. MorphoSys Humanized Monoclonal Antibody Product
Table 90. MorphoSys Revenue in Humanized Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 91. MorphoSys Recent Development
Table 92. MRC Laboratory of Molecular Biology Company Details
Table 93. MRC Laboratory of Molecular Biology Business Overview
Table 94. MRC Laboratory of Molecular Biology Humanized Monoclonal Antibody Product
Table 95. MRC Laboratory of Molecular Biology Revenue in Humanized Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 96. MRC Laboratory of Molecular Biology Recent Development
Table 97. ProMab Biotechnologies Company Details
Table 98. ProMab Biotechnologies Business Overview
Table 99. ProMab Biotechnologies Humanized Monoclonal Antibody Product
Table 100. ProMab Biotechnologies Revenue in Humanized Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 101. ProMab Biotechnologies Recent Development
Table 102. ProteoGenix Company Details
Table 103. ProteoGenix Business Overview
Table 104. ProteoGenix Humanized Monoclonal Antibody Product
Table 105. ProteoGenix Revenue in Humanized Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 106. ProteoGenix Recent Development
Table 107. Sandoz International Company Details
Table 108. Sandoz International Business Overview
Table 109. Sandoz International Humanized Monoclonal Antibody Product
Table 110. Sandoz International Revenue in Humanized Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 111. Sandoz International Recent Development
Table 112. Seattle Genetics Company Details
Table 113. Seattle Genetics Business Overview
Table 114. Seattle Genetics Humanized Monoclonal Antibody Product
Table 115. Seattle Genetics Revenue in Humanized Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 116. Seattle Genetics Recent Development
Table 117. Zyngenia Company Details
Table 118. Zyngenia Business Overview
Table 119. Zyngenia Humanized Monoclonal Antibody Product
Table 120. Zyngenia Revenue in Humanized Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 121. Zyngenia Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
Table 125. Authors List of This Report
List of Figures
Figure 1. Humanized Monoclonal Antibody Picture
Figure 2. Global Humanized Monoclonal Antibody Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Humanized Monoclonal Antibody Market Share by Type: 2024 VS 2031
Figure 4. Fully Humanized Antibody Features
Figure 5. Humanized Antibody Features
Figure 6. Chimeric Antibody Features
Figure 7. Global Humanized Monoclonal Antibody Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Humanized Monoclonal Antibody Market Share by Application: 2024 VS 2031
Figure 9. Laboratory Research Case Studies
Figure 10. Clinical Drugs Case Studies
Figure 11. Humanized Monoclonal Antibody Report Years Considered
Figure 12. Global Humanized Monoclonal Antibody Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Humanized Monoclonal Antibody Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Humanized Monoclonal Antibody Market Share by Region: 2024 VS 2031
Figure 15. Global Humanized Monoclonal Antibody Market Share by Players in 2024
Figure 16. Global Top Humanized Monoclonal Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Humanized Monoclonal Antibody as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Humanized Monoclonal Antibody Revenue in 2024
Figure 18. North America Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Humanized Monoclonal Antibody Market Share by Country (2020-2031)
Figure 20. United States Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Humanized Monoclonal Antibody Market Share by Country (2020-2031)
Figure 24. Germany Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Humanized Monoclonal Antibody Market Share by Region (2020-2031)
Figure 32. China Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Humanized Monoclonal Antibody Market Share by Country (2020-2031)
Figure 40. Mexico Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Humanized Monoclonal Antibody Market Share by Country (2020-2031)
Figure 44. Turkey Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Absolute Antibody Revenue Growth Rate in Humanized Monoclonal Antibody Business (2020-2025)
Figure 48. Amgen Revenue Growth Rate in Humanized Monoclonal Antibody Business (2020-2025)
Figure 49. Biotem Revenue Growth Rate in Humanized Monoclonal Antibody Business (2020-2025)
Figure 50. Creative Biolabs Revenue Growth Rate in Humanized Monoclonal Antibody Business (2020-2025)
Figure 51. Genentech Revenue Growth Rate in Humanized Monoclonal Antibody Business (2020-2025)
Figure 52. GenScript ProBio Revenue Growth Rate in Humanized Monoclonal Antibody Business (2020-2025)
Figure 53. Huston BioConsulting LLC Revenue Growth Rate in Humanized Monoclonal Antibody Business (2020-2025)
Figure 54. ImmunoGen Revenue Growth Rate in Humanized Monoclonal Antibody Business (2020-2025)
Figure 55. MorphoSys Revenue Growth Rate in Humanized Monoclonal Antibody Business (2020-2025)
Figure 56. MRC Laboratory of Molecular Biology Revenue Growth Rate in Humanized Monoclonal Antibody Business (2020-2025)
Figure 57. ProMab Biotechnologies Revenue Growth Rate in Humanized Monoclonal Antibody Business (2020-2025)
Figure 58. ProteoGenix Revenue Growth Rate in Humanized Monoclonal Antibody Business (2020-2025)
Figure 59. Sandoz International Revenue Growth Rate in Humanized Monoclonal Antibody Business (2020-2025)
Figure 60. Seattle Genetics Revenue Growth Rate in Humanized Monoclonal Antibody Business (2020-2025)
Figure 61. Zyngenia Revenue Growth Rate in Humanized Monoclonal Antibody Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Humanized Monoclonal Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Fully Humanized Antibody
Table 3. Key Players of Humanized Antibody
Table 4. Key Players of Chimeric Antibody
Table 5. Global Humanized Monoclonal Antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Humanized Monoclonal Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Humanized Monoclonal Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Humanized Monoclonal Antibody Market Share by Region (2020-2025)
Table 9. Global Humanized Monoclonal Antibody Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Humanized Monoclonal Antibody Market Share by Region (2026-2031)
Table 11. Humanized Monoclonal Antibody Market Trends
Table 12. Humanized Monoclonal Antibody Market Drivers
Table 13. Humanized Monoclonal Antibody Market Challenges
Table 14. Humanized Monoclonal Antibody Market Restraints
Table 15. Global Humanized Monoclonal Antibody Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Humanized Monoclonal Antibody Market Share by Players (2020-2025)
Table 17. Global Top Humanized Monoclonal Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Humanized Monoclonal Antibody as of 2024)
Table 18. Ranking of Global Top Humanized Monoclonal Antibody Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Humanized Monoclonal Antibody Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Humanized Monoclonal Antibody, Headquarters and Area Served
Table 21. Global Key Players of Humanized Monoclonal Antibody, Product and Application
Table 22. Global Key Players of Humanized Monoclonal Antibody, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Humanized Monoclonal Antibody Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Humanized Monoclonal Antibody Revenue Market Share by Type (2020-2025)
Table 26. Global Humanized Monoclonal Antibody Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Humanized Monoclonal Antibody Revenue Market Share by Type (2026-2031)
Table 28. Global Humanized Monoclonal Antibody Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Humanized Monoclonal Antibody Revenue Market Share by Application (2020-2025)
Table 30. Global Humanized Monoclonal Antibody Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Humanized Monoclonal Antibody Revenue Market Share by Application (2026-2031)
Table 32. North America Humanized Monoclonal Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Humanized Monoclonal Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Humanized Monoclonal Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Humanized Monoclonal Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Humanized Monoclonal Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Humanized Monoclonal Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Humanized Monoclonal Antibody Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Humanized Monoclonal Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Humanized Monoclonal Antibody Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Humanized Monoclonal Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Humanized Monoclonal Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Humanized Monoclonal Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Humanized Monoclonal Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Humanized Monoclonal Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Humanized Monoclonal Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 47. Absolute Antibody Company Details
Table 48. Absolute Antibody Business Overview
Table 49. Absolute Antibody Humanized Monoclonal Antibody Product
Table 50. Absolute Antibody Revenue in Humanized Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 51. Absolute Antibody Recent Development
Table 52. Amgen Company Details
Table 53. Amgen Business Overview
Table 54. Amgen Humanized Monoclonal Antibody Product
Table 55. Amgen Revenue in Humanized Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 56. Amgen Recent Development
Table 57. Biotem Company Details
Table 58. Biotem Business Overview
Table 59. Biotem Humanized Monoclonal Antibody Product
Table 60. Biotem Revenue in Humanized Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 61. Biotem Recent Development
Table 62. Creative Biolabs Company Details
Table 63. Creative Biolabs Business Overview
Table 64. Creative Biolabs Humanized Monoclonal Antibody Product
Table 65. Creative Biolabs Revenue in Humanized Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 66. Creative Biolabs Recent Development
Table 67. Genentech Company Details
Table 68. Genentech Business Overview
Table 69. Genentech Humanized Monoclonal Antibody Product
Table 70. Genentech Revenue in Humanized Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 71. Genentech Recent Development
Table 72. GenScript ProBio Company Details
Table 73. GenScript ProBio Business Overview
Table 74. GenScript ProBio Humanized Monoclonal Antibody Product
Table 75. GenScript ProBio Revenue in Humanized Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 76. GenScript ProBio Recent Development
Table 77. Huston BioConsulting LLC Company Details
Table 78. Huston BioConsulting LLC Business Overview
Table 79. Huston BioConsulting LLC Humanized Monoclonal Antibody Product
Table 80. Huston BioConsulting LLC Revenue in Humanized Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 81. Huston BioConsulting LLC Recent Development
Table 82. ImmunoGen Company Details
Table 83. ImmunoGen Business Overview
Table 84. ImmunoGen Humanized Monoclonal Antibody Product
Table 85. ImmunoGen Revenue in Humanized Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 86. ImmunoGen Recent Development
Table 87. MorphoSys Company Details
Table 88. MorphoSys Business Overview
Table 89. MorphoSys Humanized Monoclonal Antibody Product
Table 90. MorphoSys Revenue in Humanized Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 91. MorphoSys Recent Development
Table 92. MRC Laboratory of Molecular Biology Company Details
Table 93. MRC Laboratory of Molecular Biology Business Overview
Table 94. MRC Laboratory of Molecular Biology Humanized Monoclonal Antibody Product
Table 95. MRC Laboratory of Molecular Biology Revenue in Humanized Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 96. MRC Laboratory of Molecular Biology Recent Development
Table 97. ProMab Biotechnologies Company Details
Table 98. ProMab Biotechnologies Business Overview
Table 99. ProMab Biotechnologies Humanized Monoclonal Antibody Product
Table 100. ProMab Biotechnologies Revenue in Humanized Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 101. ProMab Biotechnologies Recent Development
Table 102. ProteoGenix Company Details
Table 103. ProteoGenix Business Overview
Table 104. ProteoGenix Humanized Monoclonal Antibody Product
Table 105. ProteoGenix Revenue in Humanized Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 106. ProteoGenix Recent Development
Table 107. Sandoz International Company Details
Table 108. Sandoz International Business Overview
Table 109. Sandoz International Humanized Monoclonal Antibody Product
Table 110. Sandoz International Revenue in Humanized Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 111. Sandoz International Recent Development
Table 112. Seattle Genetics Company Details
Table 113. Seattle Genetics Business Overview
Table 114. Seattle Genetics Humanized Monoclonal Antibody Product
Table 115. Seattle Genetics Revenue in Humanized Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 116. Seattle Genetics Recent Development
Table 117. Zyngenia Company Details
Table 118. Zyngenia Business Overview
Table 119. Zyngenia Humanized Monoclonal Antibody Product
Table 120. Zyngenia Revenue in Humanized Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 121. Zyngenia Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
Table 125. Authors List of This Report
List of Figures
Figure 1. Humanized Monoclonal Antibody Picture
Figure 2. Global Humanized Monoclonal Antibody Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Humanized Monoclonal Antibody Market Share by Type: 2024 VS 2031
Figure 4. Fully Humanized Antibody Features
Figure 5. Humanized Antibody Features
Figure 6. Chimeric Antibody Features
Figure 7. Global Humanized Monoclonal Antibody Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Humanized Monoclonal Antibody Market Share by Application: 2024 VS 2031
Figure 9. Laboratory Research Case Studies
Figure 10. Clinical Drugs Case Studies
Figure 11. Humanized Monoclonal Antibody Report Years Considered
Figure 12. Global Humanized Monoclonal Antibody Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Humanized Monoclonal Antibody Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Humanized Monoclonal Antibody Market Share by Region: 2024 VS 2031
Figure 15. Global Humanized Monoclonal Antibody Market Share by Players in 2024
Figure 16. Global Top Humanized Monoclonal Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Humanized Monoclonal Antibody as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Humanized Monoclonal Antibody Revenue in 2024
Figure 18. North America Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Humanized Monoclonal Antibody Market Share by Country (2020-2031)
Figure 20. United States Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Humanized Monoclonal Antibody Market Share by Country (2020-2031)
Figure 24. Germany Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Humanized Monoclonal Antibody Market Share by Region (2020-2031)
Figure 32. China Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Humanized Monoclonal Antibody Market Share by Country (2020-2031)
Figure 40. Mexico Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Humanized Monoclonal Antibody Market Share by Country (2020-2031)
Figure 44. Turkey Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Humanized Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Absolute Antibody Revenue Growth Rate in Humanized Monoclonal Antibody Business (2020-2025)
Figure 48. Amgen Revenue Growth Rate in Humanized Monoclonal Antibody Business (2020-2025)
Figure 49. Biotem Revenue Growth Rate in Humanized Monoclonal Antibody Business (2020-2025)
Figure 50. Creative Biolabs Revenue Growth Rate in Humanized Monoclonal Antibody Business (2020-2025)
Figure 51. Genentech Revenue Growth Rate in Humanized Monoclonal Antibody Business (2020-2025)
Figure 52. GenScript ProBio Revenue Growth Rate in Humanized Monoclonal Antibody Business (2020-2025)
Figure 53. Huston BioConsulting LLC Revenue Growth Rate in Humanized Monoclonal Antibody Business (2020-2025)
Figure 54. ImmunoGen Revenue Growth Rate in Humanized Monoclonal Antibody Business (2020-2025)
Figure 55. MorphoSys Revenue Growth Rate in Humanized Monoclonal Antibody Business (2020-2025)
Figure 56. MRC Laboratory of Molecular Biology Revenue Growth Rate in Humanized Monoclonal Antibody Business (2020-2025)
Figure 57. ProMab Biotechnologies Revenue Growth Rate in Humanized Monoclonal Antibody Business (2020-2025)
Figure 58. ProteoGenix Revenue Growth Rate in Humanized Monoclonal Antibody Business (2020-2025)
Figure 59. Sandoz International Revenue Growth Rate in Humanized Monoclonal Antibody Business (2020-2025)
Figure 60. Seattle Genetics Revenue Growth Rate in Humanized Monoclonal Antibody Business (2020-2025)
Figure 61. Zyngenia Revenue Growth Rate in Humanized Monoclonal Antibody Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232